|
Market Closed -
Nasdaq
02:30:00 19/11/2026 am IST
|
5-day change | 1st Jan Change | ||
| 11.25 USD | -0.71% |
|
+10.40% | +82.93% |
| 13/11 | ImmuCell Corporation, Q3 2026 Earnings Call, Nov 13, 2026 | |
| 13/11 | ImmuCell Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 | CI |
| Market Cap | 10Cr 9.32Cr 8.62Cr 7.78Cr 15Cr 954.78Cr 15Cr 104.06Cr 41Cr 515.35Cr 38Cr 38Cr 1.63TCr | P/E 2024 |
-19.5x | P/E 2025 | -51.3x |
|---|---|---|---|---|---|
| Enterprise Value | 11Cr 10Cr 9.41Cr 8.49Cr 16Cr 1.04TCr 17Cr 113.62Cr 45Cr 562.7Cr 42Cr 41Cr 1.78TCr | EV / Sales 2024 |
2.16x | EV / Sales 2025 | 2.35x |
| Free-Float |
67.83% | Yield 2024 * |
-
| Yield 2025 | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ICCC | Delayed | |
| ICCC | Real-time | ||
| IUL | Delayed |
Last Transcript: ImmuCell Corporation
| 1 day | -0.71% | ||
| 1 week | +10.40% | ||
| Current month | +9.65% | ||
| 1 month | +4.65% | ||
| 3 months | +15.27% | ||
| 6 months | +13.52% | ||
| Current year | +82.93% |
| 1 week | 10.5 | 11.72 | |
| 1 month | 9.6 | 11.72 | |
| Current year | 5.75 | 12.1 | |
| 1 year | 4.52 | 12.1 | |
| 3 years | 3.34 | 12.1 | |
| 5 years | 3.34 | 12.1 | |
| 10 years | 0 | 13.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 54 | 01/11/2025 | |
Timothy Fiori
DFI | Director of Finance/CFO | 47 | 07/04/2025 |
| Comptroller/Controller/Auditor | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Tomsche
CHM | Chairman | 69 | 01/12/2013 |
Paul Wainman
BRD | Director/Board Member | 61 | 31/03/2014 |
Gloria Basse
BRD | Director/Board Member | 66 | 10/06/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 15/04/26 | Free | Chairman | 11,933 | 0.1319% | ||
| 15/04/26 | Free | Director | 17,899 | 0.1979% | ||
| 15/04/26 | Free | Director | 11,933 | 0.1319% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.71% | +10.40% | +146.71% | +136.28% | 10Cr | ||
| -2.32% | -3.79% | +34.24% | +133.69% | 1,26100Cr | ||
| -2.15% | -2.75% | +36.35% | +82.05% | 67TCr | ||
| -2.33% | -3.04% | +22.29% | +106.80% | 52TCr | ||
| -0.69% | +0.37% | +31.53% | +69.78% | 39TCr | ||
| -3.90% | -6.39% | +42.88% | +35.41% | 35TCr | ||
| -1.35% | -0.95% | +28.90% | +56.34% | 30TCr | ||
| -1.13% | -1.80% | +0.59% | +33.00% | 28TCr | ||
| -3.07% | -5.17% | +29.04% | +67.26% | 25TCr | ||
| -0.75% | -0.44% | +32.87% | +123.96% | 21TCr | ||
| Average | -1.84% | -0.09% | +40.54% | +84.46% | 42TCr | |
| Weighted average by Cap. | -2.09% | -2.12% | +30.59% | +91.57% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.65Cr 2.42Cr 2.23Cr 2.02Cr 3.8Cr 247.57Cr 3.95Cr 27Cr 11Cr 133.63Cr 9.94Cr 9.73Cr 421.96Cr | 2.76Cr 2.52Cr 2.33Cr 2.1Cr 3.96Cr 258.32Cr 4.12Cr 28Cr 11Cr 139.43Cr 10Cr 10Cr 440.29Cr |
| Net income | -21.57L -19.67L -18.19L -16.41L -30.91L -20Cr -32.13L -2.2Cr -86.82L -11Cr -80.91L -79.21L -34Cr | -10.4L -9L -9L -8L -14.91L -9.72Cr -15.49L -1.06Cr -41.87L -5.25Cr -39.02L -38.2L -17Cr |
| Net Debt | 1.13Cr 1.03Cr 95.64L 86.31L 1.63Cr 105.98Cr 1.69Cr 12Cr 4.57Cr 57Cr 4.25Cr 4.17Cr 180.64Cr | 93.88L 85.61L 79.16L 71.44L 1.35Cr 88Cr 1.4Cr 9.56Cr 3.78Cr 47Cr 3.52Cr 3.45Cr 149.52Cr |
Employees
73
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/26/18 | $11.25 | -0.71% | 10,684 |
| 17/26/17 | $11.33 | -0.79% | 18,535 |
| 16/26/16 | $11.42 | +6.23% | 1,01,746 |
| 13/26/13 | $10.75 | +5.19% | 40,752 |
| 12/26/12 | $10.22 | +0.29% | 19,304 |
- Stock Market
- Stocks
- ICCC Stock
Select your edition
All financial news and data tailored to specific country editions
















